STEVEN I SHERMAN to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Cyclooxygenase 2 Inhibitors.
Connection Strength
0.062
-
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2006 Jun; 91(6):2201-4.
Score: 0.062
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.